(Q40548904)

21 September 2017

title

Environmental factors and membrane polyunsaturated fatty acids in schizophrenia (English)

1 reference

21 September 2017

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

3 April 2024

author name string

Ravinder D. Reddy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623491

3 April 2024

Jeffrey K. Yao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623491

3 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14623491

3 April 2024

publication date

1 December 2003

1 reference

full work available at URL

21 September 2017

https://api.elsevier.com/content/article/PII:S0952327803001613?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

https://api.elsevier.com/content/article/PII:S0952327803001613?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Prostaglandins, Leukotrienes and Essential Fatty Acids

3 April 2024

published in

1 reference

21 September 2017

volume

69

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

385-391

1 reference

Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group

21 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

3 April 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Fatty acid levels in the brains of schizophrenics and normal controls.

3 April 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

3 April 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline

3 April 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis

3 April 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Schizophrenia as a membrane lipid disorder which is expressed throughout the body

3 April 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Prevalence of smoking among psychiatric outpatients

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Schizophrenia and tobacco smoking in a Spanish psychiatric hospital.

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Smoking and schizophrenia

3 April 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Nicotine and familial vulnerability to schizophrenia: a discordant twin study

3 April 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Schizophrenia and smoking: evidence for a common neurobiological basis?

3 April 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Oxygen radicals and neuropsychiatric illness. Some speculations

3 April 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Free-radical chemistry of cigarette smoke and its toxicological implications

3 April 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Exhaled ethane and antioxidant vitamin supplements in active smokers

3 April 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Cigarette smoking and health: a radical view.

3 April 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Determinants of antioxidant status in humans

3 April 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction

3 April 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Quitting smoking raises whole blood glutathione

3 April 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Excess mortality of schizophrenia. A meta-analysis

3 April 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Association between cigarette smoking and lipid peroxidation in a controlled feeding study.

3 April 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

3 April 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Factors associated with oxidative stress in human populations

3 April 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Free radical activity in young adult cigarette smokers

3 April 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Effects of vitamin E supplementation on erythrocyte antioxidant defence mechanisms of smoking and non-smoking men

3 April 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Exhaled ethane and antioxidant vitamin supplements in active smokers

3 April 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Relationship between smoking and antioxidant nutrient status

3 April 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Association of smoking and low serum bilirubin antioxidant concentrations

3 April 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes.

3 April 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Fatty acid status of women of reproductive age

3 April 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Polyunsaturated fatty acids in adipose tissue in European men aged 38 years in relation to serum lipids, smoking habits, and fat distribution

3 April 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Long-chain polyunsaturated fatty acids, infant formula, and breastfeeding

3 April 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Regulation of PUFA metabolism: pharmacological and toxicological aspects

3 April 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Comparison of a food frequency questionnaire with a 10-day weighed record in cigarette smokers

3 April 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Relation of smoking and alcohol consumption to serum fatty acids

3 April 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

The effects of cigarette smoking on the metabolism of essential fatty acids

3 April 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia.

3 April 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

omega-3 Fatty acid for schizophrenia

3 April 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

3 April 2024

Biochemistry of Lipids

54

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Essential fatty acids and the brain

3 April 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina.

3 April 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

The Dutch famine and schizophrenia spectrum disorders

3 April 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Prenatal exposure to famine and brain morphology in schizophrenia

3 April 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Can breast-feeding protect against schizophrenia? Case-control Study

3 April 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA.

3 April 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Long‐term storage of red blood cells and correlations between red cell and dietary fatty acids: Results from a pilot study

3 April 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Human requirement for N-3 polyunsaturated fatty acids

3 April 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Essential fatty acids in plasma phospholipids in schizophrenics

3 April 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan

3 April 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

Medical comorbidity in schizophrenia

3 April 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.PLEFA.2003.08.009

3 April 2024

Identifiers

1 reference

21 September 2017

1 reference